S&P Futures
3,928.00 +30.25 (+0.78%) Dow Futures
31,401.00 +199.00 (+0.64%) Nasdaq Futures
11,999.50 +121.25 (+1.02%) Russell 2000 Futures
1,793.20 +18.30 (+1.03%) Crude Oil
110.85 -1.36 (-1.21%) Gold
1,840.80 -0.40 (-0.02%)
Takeda Pharmaceutical Company Limited (TAK)
After hours:
Chart Events
Performance Outlook
| Previous Close | 14.16 |
| Open | 14.27 |
| Bid | 0.00 x 3100 |
| Ask | 0.00 x 4000 |
| Day's Range | 14.26 - 14.68 |
| 52 Week Range | 13.17 - 17.56 |
| Volume | |
| Avg. Volume | 2,531,112 |
| Market Cap | 45.419B |
| Beta (5Y Monthly) | 1.00 |
| PE Ratio (TTM) | 11.20 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.80 (5.60%) |
| Ex-Dividend Date | Sep 29, 2021 |
| 1y Target Est | N/A |
- Business Wire
Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
OSAKA, Japan, May 11, 2022--Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2021 (period ended March 31, 2022), driven by the performance of its growth products, new product launches and strength across its key business areas.
- GlobeNewswire
CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally
Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic testing for patients with rare metabolic and rare neurodegenerative diseasesThe global market access and expansion partnership initially established in 2015 aims to provide an efficient and timely diagnosis to patientsDiagnosis remains crucial for patients, leading them towards suitable readily available t
- Business Wire
Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories
OSAKA, Japan & CAMBRIDGE, Mass., April 26, 2022--Takeda (TSE:4502/NYSE:TAK) today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the Supply Chain and Pharma 4.0™ categories for the 2022 Facility of the Year Awards (FOYA). In the Supply Chain category, Takeda was awarded for its implementation of a new patient-focused supply chain for its allogeneic mesenchymal stem cell therapy; and Takeda’s vaccine production facility in Sing
